SEC Form 4 · accession 0001209191-18-036517
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roy A Whitfield
Director
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 7:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2018 | P | 1,600 | $55.22 | A | 173,600 | D | |
| Common Stock | Jun 6, 2018 | P | 2,000 | $59.07 | A | 175,600 | D | |
| Common Stock | Jun 6, 2018 | P | 1,400 | $59.80 | A | 177,000 | D | |
| Common Stock | holding | — | — | — | 20,000 | I | by Family Trust |
Table II — derivative securities
No Table II lines on this filing.